SQUARE today symbolizes a name – a state of mind. But its journey to the growth and prosperity has been no bed of roses. From the inception in 1958, it has today burgeoned into one of the top line conglomerates in Bangladesh. Square Pharmaceuticals Ltd., the flagship company, is holding the strong leadership position in the pharmaceutical industry of Bangladesh since 1985 and is now on its way to becoming a high performance global player.
SQUARE Pharmaceuticals Limited is the largest pharmaceutical company in Bangladesh and it has been continuously in the 1st position among all national and multinational companies since 1985. It was established in 1958 and converted into a public limited company in 1991. The sales turnover of SPL was more than Taka 11.46 Billion (US$ 163.71 million) with about 16.43% market share (April 2009– March 2010) having a growth rate of about 16.72%. Corporate History: * Year of Establishment (Initially as a Partnership) | : | 1958 | * Incorporated as a Private Limited Company | : | 1964 | * Technical Collaboration Agreement with Janssen Pharmaceuticals of Belgium
(A subsidiary of Johnson & Johnson International Ltd.) | : | 1975 | * Technical Collaboration Agreement with F.Hoffman-La Roche & Co. Ltd. | : | 1984 | * Converted into Public Limited Company | : | 1991 | * Initially Public Offering (IPO) | : | 1994 | * Stock Exchange Listing (Dhaka & Chittagong) | : | 1995 | * Agreement with M/s. Bovis Tanvec Ltd. of UK for implementation of Dhaka Plant | : | 1996 | * Awarded ISO-9001 Certificate | : | 1998 | * Awarded UK-MHRA Certificate | : | 2007 | * Business Lines | : | Manufacturing and Marketing of Pharmaceutical Finished Products, Basic Chemicals, Agro Vet Products and Pesticide Products | * Authorized Capital | : | US$ 73.5 Million
(Tk. 5,000 Million) | * Paid-up Capital | : | (Tk. 1207.22 Million) | * Number of Employees | : |